Power Grid Corporation of India: The company is declared as the successful bidder under Tariff-based competitive bidding to establish inter-state transmission system for "transmission system for evacuation of power from Neemuch SEZ" on build, own operate and transfer (BOOT) basis.
#Powergrid moneycontrol trial
The said EPC project worth Rs 1,400.04 crore included trial run and operation & maintenance of the entire water supply scheme for 10 years in Madhya Pradesh. In addition, Dilip Buildcon has declared as L-1 bidder for water supply scheme tender by Madhya Pradesh Jal Nigam Maryadit, Bhopal. Standalone revenue from operations grew by 95 percent year-on-year to Rs 9,807 crore in quarter ended June 2022, and the growth compared to previous quarter was 14 percent.ĭilip Buildcon: Subsidiary 'Bangarupalem Gudipala Highways Limited' has received the financial closure letter from the National Highways Authority of India for Bangalore-Chennai Expressway in Andhra Pradesh under Bharatmala on Hybrid Annuity Mode (Phase II/Package III).
Sitagliptin is the gold standard in the Dipeptidyl peptidase 4 inhibitor (DPP4i) category with over 62 percent market share in the global market.Īvenue Supermarts: The D-Mart operator has clocked a massive 490 percent year-on-year growth in standalone profit at Rs 680 crore for the quarter ended June 2022, backed by healthy topline and operating performance but on a low base as the year-ago quarter had impacted by second covid wave, while the sequential increase in profit was nearly 46 percent. Zydus Lifesciences: Zydus has launched the molecule Sitagliptin in India under the brand names Sitaglyn and Siglyn to address Type 2 diabetes. PFRDA also approved merger of HDFC with HDFC Bank. HDFC: The Corporation has received approval from the Pension Fund Regulatory and Development Authority (PFRDA) for the merger of subsidiaries HDFC Investments Limited and HDFC Holdings Limited, with HDFC. This drug is a therapeutic generic equivalent to Toviaz brand which had US sales of approximately $211 million MAT for the most recent twelve months ending in May 2022, according to IQVIA. Profit during the quarter rose 5.2% YoY to Rs 9,478 crore, but operating margin at 23.1% contracted 2.4% YoY.ĭr Reddy's Laboratories: The pharma company has launched Fesoterodine Fumarate extended-release tablets in the US market, which are used in the treatment of certain bladder-related problems.
Tata Consultancy Services: The leading IT company reported a 16.2% year-on-year growth in revenue at Rs 52,758 crore and revenue in constant currency grew 15.5% YoY for the quarter ended June 2022. 5paisa Capital, Spandana Sphoorty Financial, Mishtann Foods, Nakoda Group of Industries, Sahara One Media & Entertainment, and Star Housing Finance will be in focus ahead of quarterly earnings on July 11.
0 kommentar(er)
